• Home/
  • Browse/
  • Changes

Prescriber Bag

Additions

Addition – Item

12222G FUROSEMIDE (FRUSEMIDE), furosemide (frusemide) 20 mg tablet, 50 (Frusemix-M, Lasix-M, Urex-M)

General Pharmaceutical Benefits

Additions

Addition – Item

12320K APOMORPHINE, apomorphine hydrochloride hemihydrate 20 mg/2 mL injection, 5 x 2 mL ampoules (Movapo)
12306Q APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules (Movapo)
12319J APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/10 mL injection, 5 x 10 mL syringes (Movapo PFS)
12300J FULVESTRANT, fulvestrant 250 mg/5 mL injection, 2 x 5 mL syringes (Fulvestrant Sandoz)
12295D INDACATEROL + GLYCOPYRRONIUM + MOMETASONE, indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 30 capsules (Enerzair Breezhaler)
12298G INDACATEROL + GLYCOPYRRONIUM + MOMETASONE, indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 68 microgram powder for inhalation, 30 capsules (Enerzair Breezhaler)
12311Y OXYCODONE, oxycodone hydrochloride 5 mg capsule, 10 (OxyNorm)
12314D OXYCODONE, oxycodone hydrochloride 5 mg capsule, 10 (OxyNorm)
12301K ROMOSOZUMAB, romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes (Evenity)
12297F SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
12307R SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
12321L SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
12299H SERTRALINE, sertraline 50 mg tablet, 30 (Sertraline tablets USP (Medsurge))
12305P SERTRALINE, sertraline 50 mg tablet, 30 (Sertraline tablets USP (Medsurge))
12296E SERTRALINE, sertraline 100 mg tablet, 30 (Sertraline tablets USP (Medsurge))
12317G SERTRALINE, sertraline 100 mg tablet, 30 (Sertraline tablets USP (Medsurge))

Addition – Brand

10756D Burprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 25 microgram/hour patch, 2
10755C Buprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 30 microgram/hour patch, 2
10746N Buprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 40 microgram/hour patch, 2
9157Y Cinacalcet Mylan, AF – CINACALCET, cinacalcet 30 mg tablet, 28
9158B Cinacalcet Mylan, AF – CINACALCET, cinacalcet 60 mg tablet, 28
9159C Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28
10022L Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 25 mg tablet, 30
10028T Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 25 mg tablet, 30
11263T Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 25 mg tablet, 30
10019H Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 100 mg tablet, 30
10020J Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 100 mg tablet, 30
11260P Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 100 mg tablet, 30
10014C Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 150 mg tablet, 30
10025P Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 150 mg tablet, 30
11259N Erlotinib Sandoz, SZ – ERLOTINIB, erlotinib 150 mg tablet, 30
11692J APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
11692J Esopreze, BG – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
12287Q APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
12287Q Esopreze, BG – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
8600P APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
8600P Esopreze, BG – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
8886Q APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
8886Q Esopreze, BG – ESOMEPRAZOLE, esomeprazole 20 mg enteric tablet, 30
12283L APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
12283L Esopreze, BG – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
3401B APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
3401B Esopreze, BG – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
8601Q APO-Esomeprazole, TY – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
8601Q Esopreze, BG – ESOMEPRAZOLE, esomeprazole 40 mg enteric tablet, 30
8516F Axotide Junior, GC – FLUTICASONE PROPIONATE, fluticasone propionate 50 microgram/actuation inhalation, 120 actuations
8147T Axotide Junior Accuhaler, GC – FLUTICASONE PROPIONATE, fluticasone propionate 100 microgram/actuation powder for inhalation, 60 actuations
8148W Axotide Accuhaler, GC – FLUTICASONE PROPIONATE, fluticasone propionate 250 microgram/actuation powder for inhalation, 60 actuations
8517G PAVTIDE MDI 50/25, GC – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation, 120 actuations
8430Q PAVTIDE ACCUHALER 100/50, GC – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 100 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations
8431R PAVTIDE ACCUHALER 250/50, GC – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations
8432T PAVTIDE ACCUHALER 500/50, GC – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations
8505P APX-Gabapentin, GX – GABAPENTIN, gabapentin 100 mg capsule, 100
1834M APX-Gabapentin, GX – GABAPENTIN, gabapentin 300 mg capsule, 100
1835N APX-Gabapentin, GX – GABAPENTIN, gabapentin 400 mg capsule, 100
9316H Nepiten, AF – NEBIVOLOL, nebivolol 1.25 mg tablet, 28
9311C Nepiten, AF – NEBIVOLOL, nebivolol 5 mg tablet, 28
9312D Nepiten, AF – NEBIVOLOL, nebivolol 10 mg tablet, 28
11683X Maxor EC Tabs, AF – OMEPRAZOLE, omeprazole 20 mg enteric tablet, 30
12272X Maxor EC Tabs, AF – OMEPRAZOLE, omeprazole 20 mg enteric tablet, 30
8331L Maxor EC Tabs, AF – OMEPRAZOLE, omeprazole 20 mg enteric tablet, 30
8333N Maxor EC Tabs, AF – OMEPRAZOLE, omeprazole 20 mg enteric tablet, 30
10460M Posaconazole ARX, XT – POSACONAZOLE, posaconazole 100 mg modified release tablet, 24
2590H Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2606E Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2584B Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2628H Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2574L Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2609H Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2594M Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30
2636R Rosuvastatin Lupin, GQ – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30
2898M Terimide, AF – TERIFLUNOMIDE, teriflunomide 14 mg tablet, 28
9288W Zoledronic Acid SUN, RA – ZOLEDRONIC ACID, zoledronic acid 5 mg/100 mL injection, 100 mL vial
9350D Zoledronic Acid SUN, RA – ZOLEDRONIC ACID, zoledronic acid 5 mg/100 mL injection, 100 mL vial

Addition – Equivalence Indicator

9157Y Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 30 mg tablet, 28
9158B Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 60 mg tablet, 28
9159C Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 90 mg tablet, 28
8516F Flixotide Junior, GK – FLUTICASONE PROPIONATE, fluticasone propionate 50 microgram/actuation inhalation, 120 actuations
8147T Flixotide Junior Accuhaler, GK – FLUTICASONE PROPIONATE, fluticasone propionate 100 microgram/actuation powder for inhalation, 60 actuations
8148W Flixotide Accuhaler, GK – FLUTICASONE PROPIONATE, fluticasone propionate 250 microgram/actuation powder for inhalation, 60 actuations
8517G Seretide MDI 50/25, GK – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation, 120 actuations
8430Q Seretide Accuhaler 100/50, GK – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 100 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations
8431R Seretide Accuhaler 250/50, GK – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations
8432T Seretide Accuhaler 500/50, GK – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations

Addition – Note

11361Y GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11365E GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11372M GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11373N GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11375Q GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11376R GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
3426H GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
3428K GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
3430M GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
3432P GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
3434R GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
3436W GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
11381B GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL pen device (Simponi)
11382C GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL pen device (Simponi)
11502J GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL pen device (Simponi)
11385F RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali)
11386G RIBOCICLIB, ribociclib 200 mg tablet, 63 (Kisqali)
11397W RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali)
10703H RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10709P RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10719E RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10742J RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
11988Y RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10425Q SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
10494H SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
10890E SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10893H SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10894J SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
10895K SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10898N SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10899P SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
10900Q SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10901R SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
10906B SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx)
10910F SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL pen devices (Cosentyx)
2236Q SERTRALINE, sertraline 50 mg tablet, 30 (APO-Sertraline, Auro-Sertraline 50, Eleva 50, NOUMED SERTRALINE, Sertra 50, Sertraline AN, Sertraline Sandoz, Sertraline generichealth, Setrona, Zoloft)
8836C SERTRALINE, sertraline 50 mg tablet, 30 (Auro-Sertraline 50, Eleva 50, NOUMED SERTRALINE, Sertraline AN, Zoloft)
2237R SERTRALINE, sertraline 100 mg tablet, 30 (APO-Sertraline, Auro-Sertraline 100, Eleva 100, NOUMED SERTRALINE, Sertra 100, Sertraline AN, Sertraline Sandoz, Sertraline generichealth, Setrona, Zoloft)
8837D SERTRALINE, sertraline 100 mg tablet, 30 (Auro-Sertraline 100, Eleva 100, NOUMED SERTRALINE, Sertraline AN, Zoloft)

Addition – Restriction

9438R AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets (GA gel)
5484P AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 25 g sachets (GA express 15)

Deletions

Deletion – Item

2002J CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 70 mL (Zinnat)
5499K CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 70 mL (Zinnat)
12025X OXYCODONE, oxycodone hydrochloride 5 mg capsule, 20 (OxyNorm, Oxycodone BNM)
12044X OXYCODONE, oxycodone hydrochloride 5 mg capsule, 20 (OxyNorm, Oxycodone BNM)

Deletion – Brand

1148K Zedace, AF – CAPTOPRIL, captopril 25 mg tablet, 90
1149L Zedace, AF – CAPTOPRIL, captopril 50 mg tablet, 90
10022L Tarceva, RO – ERLOTINIB, erlotinib 25 mg tablet, 30
10028T Tarceva, RO – ERLOTINIB, erlotinib 25 mg tablet, 30
11263T Tarceva, RO – ERLOTINIB, erlotinib 25 mg tablet, 30
10019H Tarceva, RO – ERLOTINIB, erlotinib 100 mg tablet, 30
10020J Tarceva, RO – ERLOTINIB, erlotinib 100 mg tablet, 30
11260P Tarceva, RO – ERLOTINIB, erlotinib 100 mg tablet, 30
10014C Tarceva, RO – ERLOTINIB, erlotinib 150 mg tablet, 30
10025P Tarceva, RO – ERLOTINIB, erlotinib 150 mg tablet, 30
11259N Tarceva, RO – ERLOTINIB, erlotinib 150 mg tablet, 30

Alterations

Alteration – Brand Name

From
2138M Fawns and McAllan Proprietary Limited, AS – PHENOBARBITAL (PHENOBARBITONE), phenobarbital (phenobarbitone) sodium 219 mg/mL injection, 5 x 1 mL ampoules
To
2138M Phenobarbitone Injection (Aspen Pharmacare Australia Pty Ltd), AS – PHENOBARBITAL (PHENOBARBITONE), phenobarbital (phenobarbitone) sodium 219 mg/mL injection, 5 x 1 mL ampoules

Alteration – Note

12005W CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
12040Q CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
12063X CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
12013G CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia)
12027B CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia)
12028C CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia)
12291X DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12292Y DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
11516D GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
11521J GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11538G GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11560K GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
9411H TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL pen device (Forteo)

Alteration – Restriction

11442F BARICITINIB, baricitinib 2 mg tablet, 28 (Olumiant)
11443G BARICITINIB, baricitinib 4 mg tablet, 28 (Olumiant)
12063X CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
12027B CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia)
12291X DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12292Y DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
11538G GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi)
11560K GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
11385F RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali)
11386G RIBOCICLIB, ribociclib 200 mg tablet, 63 (Kisqali)
11397W RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali)
9411H TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL pen device (Forteo)

Advance Notices

1 May 2021

Deletion – Brand

9155W Andepra, EL – DULOXETINE, duloxetine 30 mg enteric capsule, 28
9156X Andepra, EL – DULOXETINE, duloxetine 60 mg enteric capsule, 28
3050M NOUMED PERINDOPRIL, VO – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3051N NOUMED PERINDOPRIL, VO – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
8704D NOUMED PERINDOPRIL, VO – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
2011W Ransim, RA – SIMVASTATIN, simvastatin 10 mg tablet, 30
8313M Ransim, RA – SIMVASTATIN, simvastatin 80 mg tablet, 30
9242K Ransim, RA – SIMVASTATIN, simvastatin 10 mg tablet, 30
9245N Ransim, RA – SIMVASTATIN, simvastatin 80 mg tablet, 30

1 October 2021

Deletion – Brand

10703H Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10709P Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10719E Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10742J Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
11988Y Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial

Supply Only 

From 1 November 2020 when a product is deleted from the Schedule it may now be available under new Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.

Substitution of Supply Only items/brands with products flagged as "equivalent for substitution" still apply as specified in the Schedule at the time the script was written. Further information on Supply Only arrangements is available at www.pbs.gov.au

Supply Only commencing April 2021 

10687L Fraxiparine, AS – NADROPARIN, nadroparin calcium 1900 anti-Xa units/0.2 mL injection, 2 x 0.2 mL syringes 
10735B Fraxiparine, AS – NADROPARIN, nadroparin calcium 1900 anti-Xa units/0.2 mL injection, 2 x 0.2 mL syringes 
10686K Fraxiparine, AS – NADROPARIN, nadroparin calcium 2850 anti-Xa units/0.3 mL injection, 2 x 0.3 mL syringes 
10701F Fraxiparine, AS – NADROPARIN, nadroparin calcium 2850 anti-Xa units/0.3 mL injection, 2 x 0.3 mL syringes 
10685J Fraxiparine, AS – NADROPARIN, nadroparin calcium 3800 anti-Xa units/0.4 mL injection, 2 x 0.4 mL syringes 
10717C Fraxiparine, AS – NADROPARIN, nadroparin calcium 3800 anti-Xa units/0.4 mL injection, 2 x 0.4 mL syringes 
10716B Fraxiparine, AS – NADROPARIN, nadroparin calcium 5700 anti-Xa units/0.6 mL injection, 2 x 0.6 mL syringes 
10718D Fraxiparine, AS – NADROPARIN, nadroparin calcium 5700 anti-Xa units/0.6 mL injection, 2 x 0.6 mL syringes 
10734Y Fraxiparine, AS – NADROPARIN, nadroparin calcium 7600 anti-Xa units/0.8 mL injection, 2 x 0.8 mL syringes 
10740G Fraxiparine, AS – NADROPARIN, nadroparin calcium 7600 anti-Xa units/0.8 mL injection, 2 x 0.8 mL syringes 
10702G Fraxiparine, AS – NADROPARIN, nadroparin calcium 9500 anti-Xa units/mL injection, 2 x 1 mL syringes 
10733X Fraxiparine, AS – NADROPARIN, nadroparin calcium 9500 anti-Xa units/mL injection, 2 x 1 mL syringes 
10706L Fraxiparine Forte, AS – NADROPARIN, nadroparin calcium 11 400 anti-Xa units/0.6 mL injection, 2 x 0.6 mL syringes 
10725L Fraxiparine Forte, AS – NADROPARIN, nadroparin calcium 15 200 anti-Xa units/0.8 mL injection, 2 x 0.8 mL syringes 
10707M Fraxiparine Forte, AS – NADROPARIN, nadroparin calcium 19 000 anti-Xa units/mL injection, 2 x 1 mL syringes 

Palliative Care

Additions

Addition – Brand

10964C Burprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 25 microgram/hour patch, 2
10949G Buprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 30 microgram/hour patch, 2
10959T Buprenorphine Sandoz, SZ – BUPRENORPHINE, buprenorphine 40 microgram/hour patch, 2

Supply Only

From 1 November 2020 when a product is deleted from the Schedule it may now be available under new Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.

Substitution of Supply Only items/brands with products flagged as "equivalent for substitution" still apply as specified in the Schedule at the time the script was written. Further information on Supply Only arrangements is available at www.pbs.gov.au

Supply Only commencing April 2021 

5319Y Panadol, GC – PARACETAMOL, paracetamol 500 mg suppository, 24

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Item

12313C DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12316F DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12294C DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
12310X DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)

Addition – Brand

11891W Cinacalcet Mylan, AF – CINACALCET, cinacalcet 30 mg tablet, 28
9625N Cinacalcet Mylan, AF – CINACALCET, cinacalcet 30 mg tablet, 28
11889R Cinacalcet Mylan, AF – CINACALCET, cinacalcet 60 mg tablet, 28
9626P Cinacalcet Mylan, AF – CINACALCET, cinacalcet 60 mg tablet, 28
11888Q Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28
9627Q Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28

Addition – Equivalence Indicator

11891W Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 30 mg tablet, 28
9625N Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 30 mg tablet, 28
11889R Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 60 mg tablet, 28
9626P Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 60 mg tablet, 28
11888Q Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 90 mg tablet, 28
9627Q Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 90 mg tablet, 28

Deletions

Deletion – Brand

10583B Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
10576P Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
9611W Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Note

11504L BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11523L BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11847M BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11996J BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11997K BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11999M BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12030E MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12043W MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12051G MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12052H MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
11003D MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
11014Q MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
11829N MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
11826K OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
11840E OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)
11825J OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)
11864K OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Alteration – Restriction

9607P APOMORPHINE, apomorphine hydrochloride hemihydrate 20 mg/2 mL injection, 5 x 2 mL ampoules (Movapo)
9640J APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules (Movapo)
10971K APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/10 mL injection, 5 x 10 mL syringes (Movapo PFS)
11523L BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11997K BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12051G MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
11003D MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Item

12309W DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12318H DUPILUMAB, dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes (Dupixent)
12293B DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)
12302L DUPILUMAB, dupilumab 300 mg/2 mL injection, 2 x 2 mL syringes (Dupixent)

Addition – Brand

11887P Cinacalcet Mylan, AF – CINACALCET, cinacalcet 30 mg tablet, 28
5621W Cinacalcet Mylan, AF – CINACALCET, cinacalcet 30 mg tablet, 28
11886N Cinacalcet Mylan, AF – CINACALCET, cinacalcet 60 mg tablet, 28
5622X Cinacalcet Mylan, AF – CINACALCET, cinacalcet 60 mg tablet, 28
11885M Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28
5623Y Cinacalcet Mylan, AF – CINACALCET, cinacalcet 90 mg tablet, 28

Addition – Equivalence Indicator

11887P Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 30 mg tablet, 28
5621W Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 30 mg tablet, 28
11886N Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 60 mg tablet, 28
5622X Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 60 mg tablet, 28
11885M Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 90 mg tablet, 28
5623Y Pharmacor Cinacalcet, CR – CINACALCET, cinacalcet 90 mg tablet, 28

Deletions

Deletion – Brand

10591K Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
10593M Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
9544H Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Note

11529T BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11549W BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11830P BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11994G BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
11995H BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12000N BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12007Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12021Q MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12064Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
12073K MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10980X MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10996R MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
11839D MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
11835X OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
11846L OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)
11824H OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)
11828M OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Alteration – Restriction

5609F APOMORPHINE, apomorphine hydrochloride hemihydrate 20 mg/2 mL injection, 5 x 2 mL ampoules (Movapo)
5610G APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules (Movapo)
10950H APOMORPHINE, apomorphine hydrochloride hemihydrate 50 mg/10 mL injection, 5 x 10 mL syringes (Movapo PFS)
11549W BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11994G BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL pen device (Fasenra Pen)
12007Y MEPOLIZUMAB, mepolizumab 100 mg/mL injection, 1 mL pen device (Nucala)
10996R MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Highly Specialised Drugs Program (Community Access)

Additions

Addition – Brand

10310P Tenofovir Sandoz, SZ – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30
11992E Tenofovir Sandoz, SZ – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30

Growth Hormone Program

Deletions

Deletion – Item

10437H SOMATROPIN, somatropin 5 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
10469B SOMATROPIN, somatropin 5 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
6295H SOMATROPIN, somatropin 5 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
10439K SOMATROPIN, somatropin 10 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
10448X SOMATROPIN, somatropin 10 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
6296J SOMATROPIN, somatropin 10 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
10468Y SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
10470C SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)
6297K SOMATROPIN, somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge (Norditropin SimpleXx)

IVF Program

Additions

Addition – Brand

9583J GANIRELIX SUN, RA – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 0.5 mL syringe
9584K GANIRELIX SUN, RA – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 5 x 0.5 mL syringes

Addition – Equivalence Indicator

9583J Orgalutran, OQ – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 0.5 mL syringe
9584K Orgalutran, OQ – GANIRELIX, ganirelix 250 microgram/0.5 mL injection, 5 x 0.5 mL syringes

Repatriation Pharmaceutical Benefits

Advance Notices

1 June 2021

Deletion – Brand

4642H Mepilex Border 295200, MH – DRESSING FOAM WITH SILICONE HEAVY EXUDATE, dressing foam with silicone heavy exudate 7.5 cm x 7.5 cm dressing, 5
4643J Mepilex Border 295300, MH – DRESSING FOAM WITH SILICONE HEAVY EXUDATE, dressing foam with silicone heavy exudate 10 cm x 10 cm dressing, 5
 

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Item

12304N IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12308T IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12312B NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12315E NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Addition – Brand

7236W Cabazitaxel Juno, JU – CABAZITAXEL, cabazitaxel 60 mg/1.5 mL injection [1.5 mL vial] (&) inert substance diluent [4.5 mL vial], 1 pack
7249M Irinotecan Accord, OC – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial

Deletions

Deletion – Brand

10193L Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
11935E Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
7257Y Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
7258B Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
7259C Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
10193L Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
11935E Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
7257Y Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
7258B Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
7259C Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Restriction

11143L NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11152Y NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Advance Notices

1 May 2021

Deletion – Brand

7231N Epirubicin ACT, JU – EPIRUBICIN, epirubicin hydrochloride 200 mg/100 mL injection, 100 mL vial
7231N Epirubicin ACT, JU – EPIRUBICIN, epirubicin hydrochloride 50 mg/25 mL injection, 25 mL vial

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Item

12322M IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12324P IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy)
12303M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
12323N NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Addition – Brand

4376H Cabazitaxel Juno, JU – CABAZITAXEL, cabazitaxel 60 mg/1.5 mL injection [1.5 mL vial] (&) inert substance diluent [4.5 mL vial], 1 pack
4451G Irinotecan Accord, OC – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial

Deletions

Deletion – Brand

10179R Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
11936F Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
4613T Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
4614W Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
4615X Mabthera, RO – RITUXIMAB, rituximab 100 mg/10 mL injection, 2 x 10 mL vials
10179R Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
11936F Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
4613T Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
4614W Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial
4615X Mabthera, RO – RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial

Alterations

Alteration – Restriction

11153B NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)
11158G NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Advance Notices

1 May 2021

Deletion – Brand

4375G Epirubicin ACT, JU – EPIRUBICIN, epirubicin hydrochloride 200 mg/100 mL injection, 100 mL vial
4375G Epirubicin ACT, JU – EPIRUBICIN, epirubicin hydrochloride 50 mg/25 mL injection, 25 mL vial

Related Pharmaceutical Benefits for Public Hospital use

Additions

Addition – Note

10708N RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10710Q RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10720F RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
10741H RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)
11942M RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial (Mabthera SC)

Advance Notices

1 October 2021

Deletion – Brand

10708N Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10710Q Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10720F Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
10741H Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial
11942M Mabthera SC, RO – RITUXIMAB, rituximab 1.4 g/11.7 mL injection, 11.7 mL vial